ERVW-1 and neoplasm: Since both T-cell and IgG responses were higher for the HERV-WLQMV-vaccinated mice than the HERV-WWT-vaccinated mice, we were curious whether this could also reflect improved tumour protection against HERV-W Env-expressing tumours.